Long Covid Diaries, No. 49: the end.
- Condition
- Long COVID
- At worst
- Severe (mostly bedbound)
- Ill for
- 4 years
- Published
- Feb 2025
Summary
nescio13 credits a beta-blocker ("basic blood pressure reduction medication," no specific drug name or dose given) with ending their migraine-like long covid symptoms, though as a side effect it also brought back their asthma. They had lived with long covid for about four years, severe enough to require nearly complete social withdrawal and tightly controlled environments. Afterward they report being able to "walk and talk again," listen to music while writing, hold conversations, and return to teaching 340 students along with cycling, swimming and socializing. As of the February 2025 writing date the improvement had held, though they note some "new natural limits" persist and explicitly worry about declaring recovery prematurely in case new symptoms emerge.
What they credit
Credits POTS medication, Supplements, Beta-blockers.
Similar stories
-
How I got in remission/cured my ME/CFS
Ali_Mardiyev, disabled for 1.5 years with POTS/dysautonomia/severe fatigue/PEM, layered a stellate ganglion block with beta-blocker, a testosterone course, several psychiatric medications, intermittent fasting and a slow graded-exercise ramp starting April…
-
Michelle
Michelle saw more than ten specialists and tried extensive medical treatment: beta blockers, the migraine drug Ubrelvy, meclizine for dizziness, two rounds of prednisone, B12 shots for neuropathy, and Paxlovid taken months after her initial infection, plus…
-
Impact of extended-course Paxlovid in established Long COVID (Case 11)
Case 11, a 33-year-old woman roughly three years into severe Long COVID/ME since March 2020, initially bedridden and dependent on caregivers and later "mostly housebound," had a 5-day Paxlovid course in May 2022 that brought significant improvement, ending…
-
Impact of extended-course Paxlovid in established Long COVID (Case 7)
Case 7, a 29-year-old man about 10 months into Long COVID/ME since July 2022 with extreme fatigue, PEM, tachycardia, POTS, persistent headache, brain fog, chest pain and shortness of breath, took a 15-day extended Paxlovid course in May 2023 while also on…